Can Cytidine deaminase be used as predictive biomarker for gemcitabine toxicity and response?
Peters GJ, Giovannetti E, Honeywell RJ, Ciccolini J
Live
The Marseille Cancer Research Center celebrates its 50th anniversary ! -
the Team publications
MST1/Hippo promoter gene methylation predicts poor survival in patients with malignant pleural mesothelioma in the IFCT-GFPC-0701 MAPS Phase 3 trial.
Maille E, Brosseau S, Hanoux V, Creveuil C, Danel C, Bergot E, Scherpereel A, Mazières J, Margery J, Greillier L, Audigier-Valette C, Moro-Sibilot D, Molinier O, Corre R, Monnet I, Gounant V, Langlais A, Morin F, Levallet G, Zalcman G
[Diffuse esophageal leiomyomatosis and Alport’s syndrome: A case report and review of the literature].
Delteil C, Macagno N, Daniel L, D'Journo XB, Guisiano S, Garcia S, Secq V